business
Intellia Therapeutics Stock Is Down Nearly 95% From Its Record Highs but Cathie Wood Keeps Buying
Intellia Therapeutics Stock Is Down Nearly 95% From Its Record Highs but Cathie Wood Keeps Buying
Read full story on Yahoo Finance → More top storiesAlso covered by
Investing.com
US stock futures edge lower after Wall St hits record highs on Iran hopes
CNBC
SoftBank shares surge over 16% as Japan tech stock-fueled rally lifts Nikkei 225 to record highs
Investing.com
Spero Therapeutics CEO sells $63,352 in company stock
Investing.com
MapLight Therapeutics CSO sells $1.47 million in stock
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop